Fifteen (15/18—83%) of BRCA1 PSV carriers diagnosed with DCIS had high grade or intermediate to high-grade DCIS, while 4/8 (50%) of the BRCA2 PSV carriers had these DCIS grades. The gene discussed is BRCA2; the disease is ductal breast carcinoma in situ.